by mediaid pharmacy | Jan 21, 2026 | Blogs
Olanib 50 mg is an oral anti-cancer medicine containing Olaparib INN, a PARP inhibitor widely used in targeted oncology therapy. It is prescribed mainly for BRCA-mutated cancers and selected solid tumors under specialist supervision. What Is Olanib Tablet 50mg? Olanib...
by mediaid pharmacy | Jan 17, 2026 | Blogs
Cancer treatment decisions are rarely simple especially when patients and caregivers are navigating complex diagnoses like ovarian or breast cancer. Alongside emotional stress, there’s often confusion around which medicines work best, how targeted therapies differ...
by mediaid pharmacy | Jan 17, 2026 | Blogs
Breast cancer treatment has evolved rapidly over the last decade, especially with the introduction of targeted therapies that focus on specific cancer-driving mechanisms rather than broadly attacking healthy cells. For patients diagnosed with HER2-positive breast...
by mediaid pharmacy | Jan 9, 2026 | Blogs
Obetix 5 mg (Obeticholic Acid) is a prescription medication widely used in the management of primary biliary cholangitis (PBC), a chronic autoimmune liver disease that can progress to liver failure if left untreated. Obetix works by activating the farnesoid X receptor...
by mediaid pharmacy | Jan 9, 2026 | Blogs
Cabozanix 20mg & 60mg is a targeted oral oncology medication containing Cabozanitib, a multi-kinase inhibitor used in the treatment of several advanced cancers. It is commonly prescribed for renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and medullary...
